Paulson, Margaret R.
Shulman, Eliza P.
Dunn, Ajani N.
Fazio, Jacey R.
Habermann, Elizabeth B.
Matcha, Gautam V.
McCoy, Rozalina G.
Pagan, Ricardo J.
Maniaci, Michael J.
Funding for this research was provided by:
Mayo Clinic
Article History
Received: 8 August 2022
Accepted: 2 February 2023
First Online: 9 February 2023
Declarations
:
: This study was approved by the Mayo Clinic Institutional Review Board as a retrospective chart review under protocol number 20–010753 and analyzed the de-identified patient data under protocol number 21–004666. Patients provide both oral and written informed consent to participate in the ACH program. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Mayo Clinic discloses a financial investment in Medically Home LLC, the company that provides the Cesia Continuum™ software platform described in this study. Eliza P. Shulman discloses that she is the Chief Medical Officer of Medically Home LLC and has a financial investment in the company. No other authors have any personal or financial conflicts of interest to declare.